PAVMED INCPAVM
ASignal's systematic analysis rates PAVM as Bearish.
Reflects the latest available analysis · analyzed Oct 10, 2026
The case on PAVM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Revenue growth of 450.00% (YoY) indicates strong top-line expansion
- RSI at 24.85 suggests potential oversold condition
- Cash position of $4.07M provides some liquidity cushion
- Negative operating and gross margins (operating margin: -21278.79%, gross margin: -220.54%)
- Negative free cash flow of $-11.93M and negative operating cash flow of $-7.73M
- Extremely high price-to-sales ratio at 199.18x and EV/Revenue at 177.83x
- Negative ROE (-64.78%) and negative EV/EBITDA (-0.75x) indicate financial distress
- MACD below signal line with negative histogram, indicating bearish momentum
- Price below SMA20, SMA50, and EMA20, signaling strong downtrend
See the full verdict on PAVM
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PAVM
Most investors never get a second opinion, let alone several. ASignal runs PAVM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.